Sectors
TXG
10x Genomics, Inc.
62.45
2 x 44.24
2 x 75.95
bid
ask
+
0.91
1.48%
2 @ 05:52 PM
61.30 -1.15 (1.84%)
| Ytd | 282.89% | |
| 1y | 345.75% |
58.70
day range
62.64
11.16
52 week range
66.94
| Open | 60.84 | Prev Close | 61.54 | Low | 58.70 | High | 62.64 | Mkt Cap | 8.14B |
| Vol | 2.66M | Avg Vol | 3.26M | EPS | -0.59 | P/E | N/A | Forward P/E | 307.14 |
| Beta | 2.04 | Short Ratio | 4.97 | Inst. Own | 111.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 48.07 | 200-d Avg | 27.80 | 1yr Est | 49.54 |
| Income Statement | |||
| Total Revenue | 151.04M | ||
| Revenues (USD) | 151.04M | ||
| Cost of Revenue | 38.54M | ||
| Gross Profit | 112.50M | ||
| Operating Expenses | 132.05M | ||
| Research and Development Expense | 56.79M | ||
| Selling, General and Administrative Expense | 78.66M | ||
| Operating Income | -19.55M | ||
| Income Tax Expense | -714.00K | ||
| Net Income | -17.93M | ||
| Net Income Common Stock | -17.93M | ||
| Net Income Common Stock (USD) | -17.93M | ||
| Consolidated Income | -17.93M | ||
| Earnings per Basic Share | -0.14 | ||
| Earnings per Basic Share (USD) | -0.14 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -18.64M | ||
| Earning Before Interest & Taxes (USD) | -18.64M | ||
| Weighted Average Shares | 129.98M | ||
| Weighted Average Shares Diluted | 129.98M | ||
| Balance Sheet | |||
| Cash and Equivalents | 502.51M | ||
| Cash and Equivalents (USD) | 502.51M | ||
| Investments | 49.52M | ||
| Investments Current | 49.52M | ||
| Trade and Non-Trade Receivables | 50.63M | ||
| Current Assets | 674.67M | ||
| Property, Plant & Equipment Net | 272.01M | ||
| Total Assets | 1.03B | ||
| Debt Current | 12.02M | ||
| Total Debt | 78.80M | ||
| Current Liabilities | 118.51M | ||
| Debt Non-Current | 66.78M | ||
| Total Liabilities | 204.52M | ||
| Accumulated Retained Earnings (Deficit) | -1.54B | ||
| Accumulated Other Comprehensive Income | 77.00K | ||
| Shareholders Equity | 825.55M | ||
| Shareholders Equity (USD) | 825.55M | ||
| Assets Non-Current | 355.40M | ||
| Total Debt (USD) | 78.80M | ||
| Deferred Revenue | 33.29M | ||
| Goodwill and Intangible Assets | 68.08M | ||
| Inventory | 52.62M | ||
| Liabilities Non-Current | 86.01M | ||
| Trade and Non-Trade Payables | 20.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.68M | ||
| Net Cash Flow from Financing | 3.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 12.23M | ||
| Capital Expenditure | -1.59M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -6.60M | ||
| Issuance (Purchase) of Equity Shares | 3.02M | ||
| Net Cash Flow from Investing | -7.73M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 454.00K | ||
| Net Cash Flow from Operations | 16.97M | ||
| Effect of Exchange Rate Changes on Cash | -28.00K | ||
| Share Based Compensation | 25.62M | ||